News from Globe Newswire
If you want to know if Globe Newswire is credible or reliable, look no further. We rank Globe Newswire as unknown factuality. Find out more about our methodology here.
Information about Globe Newswire
Where is Globe Newswire located?Globe Newswire's WebsiteGlobe Newswire's TwitterGlobe Newswire's WikipediaMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Ownership
Learn more about Ownership categories.
Top Globe Newswire News
Latest News Stories
HashiCorp Promotes Christine Centa to Chief People Officer
Xos, Inc. Accelerates Growth with Strategic Acquisition of ElectraMeccanica
BTSE Joins Hands with AIO Exchange to Enhance Digital Asset Trading
Shanghai, China · ShanghaiGDS Holdings Limited (NASDAQ: GDS; HKEX: 9698) appoints Jamie Khoo as Chief Executive Officer of DigitalLand Holdings Limited. Ms. Khoo has served as the COO of GDS since January 2019. GDS is a leading developer and operator of high-performance data centers in China and South East Asia.See the Story
GDS Appoints Jamie Khoo As CEO of GDS International
Shanghai, China · ShanghaiGDS Holdings Limited has entered into definitive agreements for certain institutional private equity investors to subscribe for US$587 million of Series A convertible preferred shares. The Series A subscription price implies a pre-money equity valuation for GDSI of US$750 million, which is approximately US$3.92 per American Depositary Share of GDSH. This transaction is a significant step forward in the Company's strategy to obtain dedicated financing for the development of its international business.See the Story
GDS Announces Landmark US$587 Million Equity Raise For its International Business
AlzheimerSNK01 autologous NK cell therapy demonstrated a positive effect on cerebral spinal fluid and plasma Tau proteins in Alzheimer's patients. SNK01 given via a simple IV appears to cross the blood brain barrier to improve A�42/40, Tau, and alpha-synuclein protein levels in CSF. The primary endpoint was safety and secondary endpoints included changes in cognitive assessments and biomarker levels.See the Story
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
United Kingdom · United KingdomHighlights Mkango Resources (“Mkango” or the “Company”) has conditionally raised gross proceeds of £750,000 (C$1.3M) via a direct Company subscription...See the Story